TCL Archive NCI advisors table proposed $186.5 million nanotechnology research program. NCI proposed to fund three to five “centers for cancer nanotechnology excellence,” a coordinating center, and training programs. Board members said they needed more time, information, to make decision. NCI director asked board to “think big” about nanotechnology. Deputy director called nanotechnology program “transformational.” By Cancer History Project July 2, 2004
TCL Archive Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead. By Cancer History Project July 2, 2004
TCL Archive DOD funds $4.2 million gynecologic oncology research program at four institutions. By Cancer History Project July 2, 2004
TCL Archive June issue of Business & Regulatory Report included. By Cancer History Project July 2, 2004
TCL Archive NIH to ban consulting by top officials, limit outside work by other employees. By Cancer History Project June 25, 2004
TCL Archive ASCO Annual Meeting: New Therapeutic Approaches To Breast Cancer Highlighted By Cancer History Project June 25, 2004
TCL Archive Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment By Cancer History Project June 25, 2004
TCL Archive Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete. By Cancer History Project June 25, 2004